G

Genelux Corp
D

GNLX

4.10000
USD
-0.21
(-4.87%)
مغلق
حجم التداول
2,796
الربح لكل سهم
-1
العائد الربحي
-
P/E
-5
حجم السوق
156,012,261
أصول ذات صلة الأخبار المقالات

العنوان: Genelux Corp

القطاع: Healthcare
الصناعة: Biotechnology
Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec), Lung, and Pancreatic Cancer.